Sulforaphane Ameliorates Diabetes-Induced Renal Fibrosis through Epigenetic Up-Regulation of BMP-7
Background The dietary agent sulforaphane (SFN) has been reported to reduce diabetes-induced renal fibrosis, as well as inhibit histone deacetylase (HDAC) activity. Bone morphologic protein 7 (BMP-7) has been shown to reduce renal fibrosis induced by transforming growth factor-beta1. The aim of this...
Guardado en:
Autores principales: | Lili Kong, Hongyue Wang, Chenhao Li, Huiyan Cheng, Yan Cui, Li Liu, Ying Zhao |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Korean Diabetes Association
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/aa71d2dc0dc64f388810ccd4f18dfbc4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Association between Markers of Fibrosis and Heart Failure Incidence in Patients with Type 2 Diabetes Mellitus
por: Denis A. Lebedev, et al.
Publicado: (2021) -
Association between the Plasma-Glycosylated Hemoglobin A1c/High-Density Lipoprotein Cholesterol Ratio and Carotid Atherosclerosis: A Retrospective Study
por: Xiangming Hu, et al.
Publicado: (2021) -
Frequency of Parathyroid Hormone Assessment in the Evaluation of Hypercalcemia. A Comparison Between Patients With and Without a History of Malignancy in a 20-year Dataset of 20,954 Patients
por: Michael T Sheehan, et al.
Publicado: (2021) -
Experimentally induced anti-myeloperoxidase vasculitis is not attenuated in factor B or VISTA deficient mice
por: Fernanda Flórez-Barrós, et al.
Publicado: (2021) -
Social determinants of health impacting adherence to diabetic retinopathy examinations
por: Cindy X Cai, et al.
Publicado: (2021)